EP2678334 - ANTI-VIRAL COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 26.01.2018 Database last updated on 19.07.2024 | |
Former | The patent has been granted Status updated on 17.02.2017 | ||
Former | Grant of patent is intended Status updated on 06.01.2017 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states AbbVie Ireland Unlimited Company 70 Sir John Rogerson's Quay Dublin 2 / IE | [2017/16] |
Former [2015/11] | For all designated states AbbVie Bahamas Ltd. Sassoon House Shirley Street & Victoria Avenue New Providence, Nassau / BS | ||
Former [2014/01] | For all designated states Abbvie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US | Inventor(s) | 01 /
DEGOEY, David A. 8649 226th Avenue Salem Wisconsin 53168 / US | 02 /
KATI, Warren M. 152 Knobb Hill Lane Gurnee Illinois 60031 / US | 03 /
HUTCHINS, Charles W. 31005 Prairie Ridge Road Green Oaks Illinois 60048 / US | 04 /
DONNER, Pamela L. 1901 McRae Lane Mundelein Illinois 60060 / US | 05 /
KRUEGER, Allan C. 7260 Presidential Drive Gurnee Illinois 60031 / US | 06 /
RANDOLPH, John T. 304 Broadway Avenue Libertyville Illinois 60048 / US | 07 /
PATEL, Sachin V. 1259 S. Wild Meadow Road Round Lake Illinois 60073 / US | 08 /
MATULENKO, Mark A. 1875 Countryside Drive Libertyville Illinois 60048 / US | 09 /
KEDDY, Ryan G. 10046 West Hendee Road Beach Park Illinois 60087 / US | 10 /
JINKERSON, Tammie K. 11129 10th Avenue Pleasant Prairie Wisconsin 53158 / US | 11 /
LIU, Dachun 1276 Georgetown Way Vernon Hills Illinois 60061 / US | 12 /
PRATT, John K. 8210 61st Avenue Kenosha Wisconsin 53142 / US | 13 /
ROCKWAY, Todd W. 34136 N. Lavender Circle Grayslake Illinois 60030 / US | 14 /
MARING, Clarence J. 1228 W. Borders Drive Palatine Illinois 60067 / US | 15 /
HUTCHINSON, Douglas H. 160 E. Depot Street Antioch Illinois 60002 / US | 16 /
FLENTGE, Charles A. 8628 225th Avenue Salem Wisconsin 53168 / US | 17 /
WAGNER, Rolf 42530 Sheridan Oaks Drive Antioch Illinois 60002 / US | 18 /
BETEBENNER, David A. 220 Appley Avenue Libertyville Illinois 60048 / US | 19 /
SARRIS, Kathy 1309 Andover Drive Mundelein Illinois 60060 / US | 20 /
WOLLER, Kevin R. 1072 Joy Court Antioch Illinois 60002 / US | 21 /
CARROLL, William A. 2325 Ridgeway Avenue Evanston Illinois 60201 / US | 22 /
GAO, Yi 210 East Baltusrol Drive Vernon Hills Illinois 60061 / US | [2014/01] | Representative(s) | Modiano, Micaela Nadia, et al Modiano & Partners Thierschstrasse 11 80538 München / DE | [N/P] |
Former [2014/01] | Modiano, Micaela Nadia Modiano & Partners (DE) Thierschstrasse 11 80538 München / DE | Application number, filing date | 12716757.5 | 24.02.2012 | [2017/12] | WO2012US26456 | Priority number, date | US201161446800P | 25.02.2011 Original published format: US 201161446800 P | [2014/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012116257 | Date: | 30.08.2012 | Language: | EN | [2012/35] | Type: | A1 Application with search report | No.: | EP2678334 | Date: | 01.01.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.08.2012 takes the place of the publication of the European patent application. | [2014/01] | Type: | B1 Patent specification | No.: | EP2678334 | Date: | 22.03.2017 | Language: | EN | [2017/12] | Search report(s) | International search report - published on: | EP | 30.08.2012 | Classification | IPC: | C07D403/14, A61K31/4184, A61K31/4164, A61P31/14 | [2014/01] | CPC: |
C07D403/14 (EP,CN,US);
C07D401/14 (CN);
A61P31/12 (EP);
A61P31/14 (EP);
C07D207/16 (EP,US);
C07D405/14 (CN);
C07D409/14 (CN);
C07D413/14 (CN);
C07D417/14 (CN);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/01] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | ANTIVIRALE VERBINDUNGEN | [2014/01] | English: | ANTI-VIRAL COMPOUNDS | [2014/01] | French: | COMPOSÉS ANTIVIRAUX | [2014/01] | Entry into regional phase | 23.08.2013 | National basic fee paid | 23.08.2013 | Designation fee(s) paid | 23.08.2013 | Examination fee paid | Examination procedure | 23.08.2013 | Examination requested [2014/01] | 29.07.2014 | Amendment by applicant (claims and/or description) | 10.02.2015 | Despatch of a communication from the examining division (Time limit: M06) | 14.09.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 23.11.2015 | Reply to a communication from the examining division | 22.01.2016 | Despatch of a communication from the examining division (Time limit: M04) | 25.05.2016 | Reply to a communication from the examining division | 07.09.2016 | Communication of intention to grant the patent | 04.01.2017 | Fee for grant paid | 04.01.2017 | Fee for publishing/printing paid | 04.01.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.02.2015 | Opposition(s) | 02.01.2018 | No opposition filed within time limit [2018/09] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 23.11.2015 | Request for further processing filed | 23.11.2015 | Full payment received (date of receipt of payment) Request granted | 07.12.2015 | Decision despatched | 29.07.2014 | Request for further processing filed | 29.07.2014 | Full payment received (date of receipt of payment) Request granted | 08.08.2014 | Decision despatched | Fees paid | Renewal fee | 07.02.2014 | Renewal fee patent year 03 | 13.02.2015 | Renewal fee patent year 04 | 08.02.2016 | Renewal fee patent year 05 | 07.02.2017 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 24.02.2012 | AL | 22.03.2017 | AT | 22.03.2017 | CY | 22.03.2017 | CZ | 22.03.2017 | DK | 22.03.2017 | EE | 22.03.2017 | FI | 22.03.2017 | HR | 22.03.2017 | LT | 22.03.2017 | LV | 22.03.2017 | MC | 22.03.2017 | MK | 22.03.2017 | NL | 22.03.2017 | PL | 22.03.2017 | RO | 22.03.2017 | RS | 22.03.2017 | SE | 22.03.2017 | SI | 22.03.2017 | SK | 22.03.2017 | SM | 22.03.2017 | TR | 22.03.2017 | BG | 22.06.2017 | NO | 22.06.2017 | GR | 23.06.2017 | IS | 22.07.2017 | PT | 24.07.2017 | [2020/34] |
Former [2020/31] | HU | 24.02.2012 | |
AT | 22.03.2017 | ||
CY | 22.03.2017 | ||
CZ | 22.03.2017 | ||
DK | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
MC | 22.03.2017 | ||
MK | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SI | 22.03.2017 | ||
SK | 22.03.2017 | ||
SM | 22.03.2017 | ||
TR | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
PT | 24.07.2017 | ||
Former [2020/28] | HU | 24.02.2012 | |
AT | 22.03.2017 | ||
CZ | 22.03.2017 | ||
DK | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
MC | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SI | 22.03.2017 | ||
SK | 22.03.2017 | ||
SM | 22.03.2017 | ||
TR | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
PT | 24.07.2017 | ||
Former [2020/15] | AT | 22.03.2017 | |
CZ | 22.03.2017 | ||
DK | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
MC | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SI | 22.03.2017 | ||
SK | 22.03.2017 | ||
SM | 22.03.2017 | ||
TR | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
PT | 24.07.2017 | ||
Former [2018/44] | AT | 22.03.2017 | |
CZ | 22.03.2017 | ||
DK | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
MC | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SI | 22.03.2017 | ||
SK | 22.03.2017 | ||
SM | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
PT | 24.07.2017 | ||
Former [2018/14] | AT | 22.03.2017 | |
CZ | 22.03.2017 | ||
DK | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SI | 22.03.2017 | ||
SK | 22.03.2017 | ||
SM | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
PT | 24.07.2017 | ||
Former [2018/09] | AT | 22.03.2017 | |
CZ | 22.03.2017 | ||
DK | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SK | 22.03.2017 | ||
SM | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
PT | 24.07.2017 | ||
Former [2017/51] | AT | 22.03.2017 | |
CZ | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SK | 22.03.2017 | ||
SM | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
PT | 24.07.2017 | ||
Former [2017/50] | AT | 22.03.2017 | |
CZ | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
NL | 22.03.2017 | ||
PL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SK | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
Former [2017/49] | AT | 22.03.2017 | |
CZ | 22.03.2017 | ||
EE | 22.03.2017 | ||
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
NL | 22.03.2017 | ||
RO | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
SK | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
IS | 22.07.2017 | ||
Former [2017/48] | CZ | 22.03.2017 | |
FI | 22.03.2017 | ||
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
NL | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | ||
Former [2017/41] | FI | 22.03.2017 | |
HR | 22.03.2017 | ||
LT | 22.03.2017 | ||
LV | 22.03.2017 | ||
NL | 22.03.2017 | ||
RS | 22.03.2017 | ||
SE | 22.03.2017 | ||
BG | 22.06.2017 | ||
NO | 22.06.2017 | ||
GR | 23.06.2017 | Cited in | International search | [XI]WO2010144646 (ABBOTT LAB [US], et al) [X] 1-15 * see the claims, the example, especially example 184 and the pharmacological acitivity as inhibitors of HCV replication * [I] 1-15 | by applicant | US2010317568 | US2011092415 | US2011207699 | US2009076076 | US5095153 | - BUNGARD, H., DESIGN OF PRODRUGS, ELSEVIER, (1985), pages 7 - 24 | - NEVAR ET AL., SYNTHESIS, (2000), pages 1259 - 1262 | - CHONG ET AL., TETRAHEDRON: ASYMMETRY, (1995), vol. 6, pages 409 - 418 | - LI ET AL., TETRAHEDRON, (2007), vol. 63, pages 8046 - 8053 | - ALDOUS ET AL., TETRAHEDRON: ASYMMETRY, (2000), vol. 11, pages 2455 - 2462 | - MASUI ET AL., SYNLETT, (1997), pages 273 - 274 | - JING ET AL., ADV. SYNTH. CATAL., (2005), vol. 347, pages 1193 - 1197 | - SATO ET AL., SYNTHESIS, (2004), pages 1434 - 1438 | - SYNTHESIS, (2003), pages 2507 - 2510 | - PENNING ET AL., BIOORG. MED. CHEM., (2008), vol. 16, pages 6965 - 6975 | - SYNLETT, (2003), pages 1427 - 1430 | - MEYER ET AL., SYNTHESIS, (2005), pages 945 - 956 | - MEYER ET AL., SYNLETT, (2003), pages 1427 - 1430 | - SYNTHESIS, (2005), pages 945 - 956 | - TETRAHEDRON, (2003), pages 2701 - 2712 | - TET. LETT., (2003), pages 5807 - 5810 | - J. AM. CHEM. SOC., (1965), page 1353,1358 | - J. ORG. CHEM., (1972), page 4075,4076,4077 | - BIOORG. MED. CHEM. LETT., (2009), page 5684,5686 | - J. AM. CHEM. SOC, (1951), vol. 73, page 5171 | - CHARIFSON, P.S. ET AL., J. MED. CHEM., (2008), vol. 51, pages 5243 - 5263 | - PATEL ET AL., J MEDICINAL CHEMISTRY, (2006), vol. 49, no. 25, page 7450 |